Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03247075
Other study ID # DNR 2017/1027-31/2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 19, 2017
Est. completion date October 30, 2020

Study information

Verified date January 2021
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Social anxiety disorder among youth is highly prevalent and causes significant impairment in the lives of the affected. In spite of cognitive behavior therapy (CBT) being an effective treatment, research suggests that many young people with this disorder do not have access to good-quality CBT. Internet-delivered CBT could be an effective method to increase availability of evidence-based treatments for youth with social anxiety disorder. The primary objective of this study is to test the efficacy of internet-delivered CBT (ICBT) for youth (10 - 17 years) with social anxiety disorder. The investigators aim to conduct a randomized controlled trial with N = 101 participants. Participants will be randomized to either the active treatment arm (guided ICBT) or to a control condition (guided internet-delivered support and counseling). Follow-ups will be conducted at 3 and 12 months after post-assessment.


Recruitment information / eligibility

Status Completed
Enrollment 103
Est. completion date October 30, 2020
Est. primary completion date April 30, 2019
Accepts healthy volunteers No
Gender All
Age group 10 Years to 17 Years
Eligibility Inclusion Criteria: - A principal diagnosis of social anxiety disorder, as defined by DSM-5 - Age between 10 and 17 years - Ability to read and write Swedish - Daily access to the internet through a computer or similar device - A parent or caregiver that is able to co-participate in the treatment - Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment Exclusion Criteria: - Diagnosed with autism spectrum disorder, psychosis, bipolar disorder or severe eating disorder - Present risk of suicide - Ongoing alcohol or substance abuse - Occurrence of domestic violence - Completed CBT for any anxiety disorder within the last 6 months (defined as at least 5 sessions of CBT including in vivo exposure sessions)

Study Design


Intervention

Behavioral:
Cognitive Behavior Therapy
Guided Internet-delivered CBT includes exposure training, coping techniques and cognitive components, intended to reduce social anxiety symptoms
Support and Counseling
Guided Internet-delivered support and counseling includes educative material about social anxiety and health related issues such as physical activity, nutritious diet, sleep habits etc.

Locations

Country Name City State
Sweden BUP KFE Stockholm Stockholms County

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinician Severity Rating (CSR) A 0-8 rating by a professional assessor, specifying the severity of social anxiety 6 months (14 months including follow-up)
Secondary Anxiety Disorder Interview Schedule for DSM-IV, child and parent versions (ADIS C/P) - Social anxiety disorder Diagnostic status: Social anxiety disorder Measured over the course of 6 months (14 months including follow-up)
Secondary Anxiety Disorder Interview Schedule for DSM-IV, child and parent versions (ADIS C/P) - Comorbid disorders Diagnostic status: Comorbid psychiatric disorders Measured over the course of 6 months (14 months including follow-up)
Secondary Clinical Global Impression - Improvement (CGI-I) A 1-7 rating by a professional assessor, specifying the degree of improvement from treatment Measured over the course of 3 months (12 months including follow-up)
Secondary Children's Global Assessment Scale (CGAS) A 0-100 rating by a professional assessor, specifying global functioning Measured over the course of 6 months (14 months including follow-up)
Secondary Liebowitz social anxiety scale for children and adolescents (LSAS-CA) - Child version A self-rated measure of severity of social anxiety 6 months (14 months including follow-up)
Secondary Liebowitz social anxiety scale for children and adolescents (LSAS-CA) - Parent version A parent-rated measure of severity of social anxiety Measured over the course of 6 months (14 months including follow-up)
Secondary Revised Children´s Anxiety and Depression Scale - (RCADS) - Parent version A parent-rated measure of severity of anxiety and depression Measured over the course of 6 months (14 months including follow-up)
Secondary Revised Children´s Anxiety and Depression Scale - (RCADS) Depression sub scale - Child version A parent-rated measure of severity of anxiety and depression Measured over the course of 6 months (14 months including follow-up)
Secondary Anticipatory social behaviors scale (ASBQ) A self-rated measure of anticipatory anxiety before social situations Measured over the course of 6 months (14 months including follow-up)
Secondary Post-event processing questionnaire revised (PEPQ-R) A self-rated measure of anxiety and rumination experienced after social situations Measured over the course of 6 months (14 months including follow-up)
Secondary Focus of attention questionnaire (FAQ) A self-rated measure of self-focus in social situations Measured over the course of 6 months (14 months including follow-up)
Secondary The Subtle Avoidance Frequency Examination (SAFE) A self-rated measure of safety behaviors in social situations Measured over the course of 6 months (14 months including follow-up)
Secondary The Child Health Utility 9D (CHU 9D) - Child version A self-rated measure of quality of life Measured over the course of 6 months (14 months including follow-up)
Secondary Client Satisfaction Questionnaire (CSQ-) - Child version A self-rated measure of treatment satisfaction Measured only at post-treatment
Secondary Client Satisfaction Questionnaire (CSQ-) - Parent version A parent-rated measure of treatment satisfaction Measured only at post-treatment
Secondary Treatment credibility and expectancy - Child version A self-rated measure of credibility and expectancy of allocated treatment condition Measured at one time-point, at week three in the allocated intervention.
Secondary Treatment credibility and expectancy - Parent version A parent-rated measure of credibility and expectancy of allocated treatment condition Measured at one time-point, at week three in the allocated intervention.
Secondary Education, Work and Social Adjustment Scale (EWSAS) - Parent version A parent-rated measure of functioning in everyday life Measured over the course of 6 months (14 months including follow-up)
Secondary Hospital Anxiety and Depression Scale (HADS) A self-rated measure of anxiety and depression among parents Measured only at pre-treatments
Secondary Alcohol Disorder Identification Test (AUDIT) A self-rated screening measure for hazardous and harmful alcohol consumption Measured over the course of 6 months (14 months including follow-up)
Secondary Drug Use Disorders Identification Test (DUDIT) A self-rated screening measure for drug-related problems Measured over the course of 6 months (14 months including follow-up)
Secondary Family Accommodation Scale-Anxiety (FASA) A parent-rated measure of parental accommodation to the child's anxiety Measured over the course of 6 months (14 months including follow-up)
Secondary Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) - Child version A parent-rated measure of direct and indirect costs related to psychiatric illness in children Measured over the course of 6 months (14 months including follow-up)
Secondary The Negative Effects Questionnaire (NEQ) A self-rated measure of treatment related adverse and unwanted events Measured only at post-treatment
Secondary Internet intervention Patient Adherence Scale (iiPAS) A clinician-rated measure of adherence to the allocated treatment Measured at mid-treatment (week 5) and at post-treatment (week 10)
Secondary School absenteeism A parent-rated measure of the frequency of school absenteeism Measured over the course of 6 months (14 months including follow-up)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06274112 - Using TMS to Understand Neural Processes of Social Motivation N/A
Completed NCT02554929 - Treatment of Social Anxiety Disorder and Selective Mutism N/A
Completed NCT00684541 - Interpretation Modification Program for Social Phobia N/A
Completed NCT00684320 - Attention Disengagement Training for Social Phobia N/A
Completed NCT02811458 - Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders N/A
Withdrawn NCT04622930 - Waitlist-Control Trial of Smartphone CBT for Social Anxiety Disorder (SAD) N/A
Active, not recruiting NCT05018312 - Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety N/A
Completed NCT05858294 - The Safety, Acceptability and Efficacy of Alena N/A
Active, not recruiting NCT05600114 - Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder Phase 2
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Not yet recruiting NCT02924610 - Brief Intervention to Reduce Fear Phase 4
Active, not recruiting NCT02592564 - Brain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder N/A
Recruiting NCT02305537 - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment N/A
Terminated NCT03764644 - Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders N/A
Unknown status NCT01712321 - Study of Vilazodone to Treat Social Anxiety Disorder N/A
Completed NCT01320800 - CBT for Social Anxiety Disorder Delivered by School Counselors Phase 2
Completed NCT00773162 - Flushing in Social Anxiety Disorder on Seroquel Phase 3
Completed NCT00485888 - Flushing in Social Anxiety Disorder on Cipralex Phase 2
Completed NCT00485615 - An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia Phase 2
Completed NCT00872820 - Examining Long-Term Effects and Neural Mediators of Behavioral Treatments for Social Anxiety Disorder N/A